Crinetics Pharmaceuticals's market cap is currently $3.29B. The company's EPS TTM is $-3.717; its P/E ratio is ―; Crinetics Pharmaceuticals is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.89. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 4.01M	$ 4.74M	$ 1.08M	$ 71.00K	$ 1.19M
Gross Profit	$ 4.01M	$ 3.35M	$ -184.00K	$ -56.93M	$ 80.00K
Operating Income	$ -222.61M	$ -167.88M	$ -107.70M	$ -74.95M	$ -53.83M
EBITDA	$ -221.51M	$ -166.90M	$ -106.78M	$ -72.59M	$ -49.31M
Net Income	$ -214.53M	$ -159.95M	$ -106.72M	$ -72.86M	$ -49.53M
Balance Sheet
Cash & Short-Term Investments	$ 558.55M	$ 334.43M	$ 333.71M	$ 170.88M	$ 118.39M
Total Assets	$ 635.35M	$ 352.18M	$ 351.01M	$ 183.44M	$ 130.38M
Total Debt	$ 51.73M	$ 2.02M	$ 3.07M	$ 4.01M	$ 4.85M
Net Debt	$ -3.17M	$ -30.65M	$ -197.62M	$ -89.07M	$ -35.48M
Total Liabilities	$ 96.25M	$ 35.85M	$ 19.07M	$ 14.53M	$ 13.24M
Stockholders' Equity	$ 539.11M	$ -439.17M	$ -275.25M	$ -167.61M	$ -93.80M
Cash Flow
Free Cash Flow	$ -171.00M	$ -116.86M	$ -89.02M	$ -62.21M	$ -46.87M
Operating Cash Flow	$ -166.31M	$ -115.20M	$ -88.59M	$ -62.03M	$ -46.38M
Investing Cash Flow	$ -200.41M	$ -173.98M	$ -56.48M	$ 217.00K	$ 41.67M
Financing Cash Flow	$ 388.94M	$ 121.96M	$ 252.68M	$ 114.57M	$ 67.00K

Currency in USD

Crinetics Pharmaceuticals Earnings and Revenue History

Income Statement >

Crinetics Pharmaceuticals Debt to Assets

Balance Sheet >

Crinetics Pharmaceuticals Cash Flow

Cash Flow >

Crinetics Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing